KRAS and squamous cell carcinoma: A high-throughput genotyping platform showed that squamous cell carcinoma and adenocarcinoma have distinct molecular profiles; KRAS mutations were identified only in adenocarcinoma and EGFR mutation was detected only in squamous cell carcinoma [28].